Delivery Order SPE2DB20D1109-SPE2DB25FP51P
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,602.94 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,136.53 for RINVOQ ER 15 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,847.74 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for RINVOQ ER 15mg tablets (30-count supply), with a ceiling value of $13,367.72. This firm fixed-price delivery order, with a completion date of September 16, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $3,111.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count) on July 14, 2025, with completion due July 15, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,326.30 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packaging) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,518.13 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within the pharmaceutical supply chain serving federal medical procurement needs. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $117,970.28 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. The product will be performed and delivered from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $36,535.91 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfilling immediate pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...